Pharma acquisition Insight: Hikma Pharmaceuticals to acquire Medlac Pharma

Hikma Wednesday said it had a deal to buy Medlac Pharma Italy Co., a Vietnamese injectables manufacturing company established a decade ago as a Vietnamese and Italian joint venture. The acquisition includes an injectables facility in Hanoi which began production in 2012.

It also includes adjacent vacant land, Medlac’s portfolio of 23 injectable products, as well as its pipeline and all employees. Its drugs include anti-infectives and cardiovascular products. Terms of the deal were not disclosed.

Some drugmakers, like Sanofi, have been manufacturing drugs in Vietnam for years while others have established themselves with manufacturing facilities more recently. In 2016, AbbVie acquired Glomed, a deal that gave the pharma giant two manufacturing facilities.